Skip to main content

Table 1 Demographic and clinical characteristics of patients hospitalized with severe acute respiratory infection (SARI) cases in Egypt, 2010–2014

From: Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010–2014

Characteristic

Viruses Not Identified (n = 2,132) N (%)

Enrolled SARI cases (n = 1,075) N (%)

P*

RSV (n = 485) N (%)

P$

Multiple Viruses (n = 174) N (%)

P$

PIV (n = 125) N (%)

P$

Adeno-Virus (n = 105) N (%)

P$

Influenza Viruses (n = 77) N (%)

P$

Demographics

Gender

 Female

810 (38)

569 (53)

0.562

257 (53)

1.000

90 (52)

0.741

65 (52)

0.449

47 (45)

0.081

48 (62)

0.054

 Male

1,322 (62)

506 (47)

 

228 (47)

 

84 (48)

 

60 (48)

 

58 (55)

 

29 (38)

 

Age in years

 Mean ± SD

16.96 ± 25.3

5.74 ± 13.8

 

3.15 ± 9.64

 

5.48 ± 12.55

 

6.48 ± 14.82

 

4.48 ± 11.12

 

19.52 ± 23.47

 

 Median

1.0

1.0

 

0.67

 

1.0

 

1.0

 

1.0

 

5.0

 

 (Range)

(0–90)

(0–85)

 

(0–85)

 

(0–77)

 

(0–74)

 

(0–57)

 

(0–76)

 

 < 18 years

1,493 (70)

981 (91)

0.000

470 (97)

0.000

162 (93)

0.143

111 (89)

0.523

97 (92)

0.330

47 (61)

0.000

 < 1 year

831

501

 

269

 

73

 

59

 

29

 

23

 

 1–5 years

567

384

 

165

 

66

 

46

 

52

 

17

 

 >  5 years

95

96

 

36

 

23

 

6

 

16

 

7

 

 >  18 years

639 (30)

94 (9)

 

15 (3)

 

12 (7)

 

14 (11)

 

8 (8)

 

30 (39)

 

Signs & symptoms at presentation

 Shortness of breath

1,555 (73)

1,033 (96)

0.000

485 (100)

NA

174 (100)

NA

125 (100)

NA

105 (100)

NA

77 (100)

NA

 Sore throat

654 (31)

273 (25)

0.001

174 (36)

0.001

35 (20)

0.087

33 (26)

0.429

18 (17)

0.024

18 (23)

0.394

 Sputum production

1,169 (55)

566 (53)

0.077

254 (52)

0.902

86 (49)

0.396

66 (53)

0.524

63 (60)

0.068

46 (60)

0.120

 Hemoptysis

62 (3)

20 (2)

0.047

5 (1)

0.110

4 (2)

0.869

3 (2)

0.426

2 (2)

0.599

3 (4)

0.175

 Body aches

153 (7)

165 (15)

0.000

60 (12)

0.005

30 (17)

0.490

26 (21)

0.060

22 (21)

0.065

10 (13)

0.391

 Tachypnea

1,732 (81)

1,000 (93)

0.000

442 (91)

0.362

154 (88)

0.292

108 (86)

0.459

98 (93)

0.084

74 (96)

0.038

 Nasal congestion

300 (14)

647 (60)

0.000

322 (66)

0.161

113 (65)

0.244

69 (55)

0.128

53 (50)

0.397

30 (39)

0.131

 Wheezing

360 (17)

881 (82)

0.000

414 (85)

0.186

141 (81)

0.342

108 (86)

0.123

82 (78)

0.455

42 (55)

0.000

 Stridor

22 (1)

7 (0.6)

0.127

3 (0.6)

1.000

0 (0)

0.606

1 (0)

0.586

1 (0)

0.514

2 (0)

0.052

 Abnormal Breath

Sounds

955 (45)

558 (52)

0.159

239 (49)

0.140

84 (48)

0.314

74 (59)

0.054

60 (57)

0..256

49 (64)

0.023

 Nausea or vomiting

209 (10)

116 (11)

0.360

54 (11)

1.000

29 (17)

0.011

12 (10)

0.349

8 (7)

0.174

5 (6)

0.401

 Convulsions

63 (3)

108 (10)

0.000

44 (9)

0.245

18 (10)

0.891

15 (12)

0.284

17 (16)

0.026

8 (10)

0.215

Comorbidities

 Chronic Resp disease

343 (16)

460 (43)

0.002

227 (47)

0.062

52 (30)

0.044

35 (28)

0.066

45 (43)

0.078

35 (45)

0.053

 Asthma

87

119

 

77

 

22

 

21

 

28

 

26

 

 COPD

42

66

 

13

 

6

 

2

 

0

 

4

 

 Bronchiectasis

101

133

 

88

 

11

 

9

 

12

 

2

 

 Othersa

113

142

 

49

 

13

 

3

 

5

 

3

 

 Cardiac disease

512 (24)

214 (20)

0.392

81 (17)

0.046

37 (21)

0.050

31 (25)

0.078

26 (25)

0.055

12 (16)

0.158

 Heart failure

299

44

 

22

 

13

 

14

 

9

 

7

 

 Congenital HD

114

147

 

48

 

15

 

11

 

15

 

2

 

 Cardiomyopathy

99

23

 

11

 

9

 

6

 

2

 

3

 

 Endocrine disease

147 (7)

124 (12)

0.000

50 (10)

0.249

19 (11)

0.897

24 (19)

0.004

13 (12)

0.420

12 (16)

0.158

 Diabetes mellitus

100

106

 

37

 

12

 

21

 

11

 

11

 

 Obesity

47

18

 

13

 

7

 

3

 

2

 

1

 

 Neuromuscular

disease

176 (8)

90 (8)

0.001

30 (6)

0.033

15 (9)

0.063

19 (15)

0.012

10 (10)

0.398

6 (8)

0.233

 Muscle dis

123

37

 

13

 

11

 

12

 

6

 

4

 

 Epilepsy

53

53

 

17

 

4

 

7

 

4

 

2

 

 Renal disease

43 (2)

11 (1)

0.951

5 (1)

0.866

0 (0)

0.322

3 (2)

0.198

0 (0)

0.314

2 (3)

0.200

 Chronic RF

34

9

 

5

   

3

   

2

 

 Nephrotic Syndrome

9

2

 

0

   

0

   

0

 

 Hepatic disease

54 (3)

9 (1)

0.002

2 (0.5)

0.001

3 (2)

0.192

2 (2)

0.277

1 (1)

0.579

1 (1)

0.496

 Ch hepatitis

9

5

 

2

 

2

 

0

 

1

 

1

 

 Liver cirrhosis

33

3

 

0

 

1

 

2

 

0

 

0

 

 Hepatic failure

12

1

 

0

 

0

 

0

 

0

 

0

 

 Hematologic disease

23 (1)

5 (0.5)

0.583

0 (0)

0.051

1 (0.5)

0.428

1 (1)

0.377

2 (2)

0.079

1 (1)

0.496

Clinical course

 Pneumonia

175 (8)

29 (3)

0.004

13 (2.6)

0.033

4 (2)

0.066

1 (1)

0.288

4 (4)

0.054

3 (4)

0.299

 Admission to ICU

606 (28)

219 (20)

0.000

82 (17)

0.022

41 (23)

0.123

20 (16)

0.007

22 (21)

0.064

36 (47)

0.045

 Mechanical ventilation

221 (10)

100 (9)

0.412

43 (9)

0.052

13 (7)

0.778

8 (6)

0.373

7 (7)

0.213

17 (22)

0.001

Complications

 Respiratory failure

45 (2)

22 (2)

0.033

9 (2)

0.552

4 (2)

0.488

2 (2)

0.607

4 (4)

0.101

1 (1)

0.349

 ARDS

3 (0.1)

15 (1.5)

0.011

8 (2)

0.063

4 (2)

0.072

0 (0)

0.237

0 (0)

0.064

0 (0)

0.078

Outcomes$

 Discharged

1,852 (87)

956 (89)

0.005

433 (89)

0.045

153 (88)

0.051

116 (93)

0.289

100 (95)

0.131

62 (81)

0.006

 Transferred

174 (8)

95 (8.8)

 

40 (8.6)

 

20 (11.5)

 

7 (6)

 

3 (3)

 

10 (13)

 

 Died

106 (5)

24 (2.2)

 

12 (2.4)

 

4 (2)

 

1 (1)

 

2 (2)

 

4 (5)

 
  1. *P for comparison between virus-infected (SARI-positive) and non-infected (SARI-negative) individuals. P$ for SARI patients with a positive result for that pathogen compared to a reference group of tested SARI patients with a negative result for that pathogen. RSV Respiratory syncytial virus, PIV Para-influenza virus, ICU Intensive care unit, ARDS Acute respiratory distress syndrome, NA Not available a Others; immotile cilia syndrome, interstitial lung disease